印度“格列衛(wèi)案”判決:解決知識產(chǎn)權(quán)及公共健康問題的新路徑
發(fā)布時間：2018-08-17 08:48
【摘要】：印度最高法院關(guān)于格列衛(wèi)案的判決吸引了國際社會的廣泛關(guān)注,不僅關(guān)系到印度新修改的專利法對藥品專利問題的態(tài)度,也影響了廣大發(fā)展中國家低收入患者的藥品可得性問題。印度作為公共健康問題較為嚴(yán)重的發(fā)展中國家,非常重視公共健康問題的解決,重視對本國制藥企業(yè)的保護(hù)。該案判決為發(fā)展中國家解決公共健康問題提供了有益的借鑒,在TRIPs協(xié)議框架下,主權(quán)國家完全可以在公共健康問題的解決方面做得更多。
[Abstract]:The decision of the Supreme Court of India in the Glebeth case attracted wide attention from the international community, not only in relation to the attitude of India's newly amended patent law to the issue of drug patents, It also affects the availability of drugs for low-income patients in developing countries. As a developing country with serious public health problems, India attaches great importance to the solution of public health problems and the protection of its pharmaceutical enterprises. The decision provides a useful reference for developing countries to solve public health problems. Under the framework of TRIPs, sovereign states can do more to solve public health problems.
【作者單位】： 吉林大學(xué);
【分類號】：D935.1;DD913
，
本文編號：2187094
[Abstract]:The decision of the Supreme Court of India in the Glebeth case attracted wide attention from the international community, not only in relation to the attitude of India's newly amended patent law to the issue of drug patents, It also affects the availability of drugs for low-income patients in developing countries. As a developing country with serious public health problems, India attaches great importance to the solution of public health problems and the protection of its pharmaceutical enterprises. The decision provides a useful reference for developing countries to solve public health problems. Under the framework of TRIPs, sovereign states can do more to solve public health problems.
【作者單位】： 吉林大學(xué);
【分類號】：D935.1;DD913
，
本文編號：2187094
本文鏈接：http://sikaile.net/falvlunwen/falilunwen/2187094.html
